M-Line Pharmacy
M-Line Pharmacy provides customized therapeutic solutions to meet patients' individual needs.
About Us
A Holistic Approach to Pharmacy at M-Line Pharmacy
At M-Line Pharmacy we recognize that each person in the world is unique, their physiology is as singular to them as their fingerprints. Our approach to pharmacy emphasizes the well-being of the whole person; we strongly believe in a multidisciplinary approach to help our patients live their lives to the fullest.
Our Services
Compounded Medications
M-Line's Pharmacy Compounding Division can produce lactose-free, sugar-free, gluten-free,
caffeine-free or soy-free compounded medications. Please let us know if you require the
removal of an ingredient from any compound we are making for you.
Sterile Compounding
It is the preparation of pharmaceutical compounds in a sterile environment to prevent
contamination and maintain patient safety. These products range from injections, inhaled
solutions, ophthalmic preparations or irrigation solutions made to suit an individual's
specific needs.
Pill Packs
Have you ever sat there wondering if you took your medications that morning? Do you take your
medicines at the right time? We can help you and your loved ones track their medications or
supplements. Our pharmacists can prepare a blister pack for you or a loved one.
Clinical Trials
| Trial Overview | Details |
|---|---|
| Study Title | Phase 3 Blinded Randomized Controlled Trial - Multiprofen-CC™ to Reduce Pain After Total Knee Arthroplasty |
| Regulatory Approvals | Health Canada Clinical Trial Control #: 287614 ClinicalTrials.gov ID: NCT06202989 Click here to read |
| Primary Outcome | Pain Reduction |
| Secondary Outcomes |
|
| Patient Enrollment | Ongoing (288 patients; fully powered for primary outcome measure) |
| Estimated Completion | Winter 2025 |
| Trial Overview | Details |
|---|---|
| Study Title | Phase 3 Crossover Randomized Controlled Trial - Multiprofen-CC to Reduce Pain in Hand Arthritis |
| Regulatory Approvals | Health Canada Clinical Trial Control #: 297848 ClinicalTrials.gov ID: NCT06202989 Click here to read |
| Primary Outcome | Pain Reduction |
| Secondary Outcomes |
|
| Patient Enrollment | Ongoing (88 patients; fully powered for primary outcome measure) |
| Estimated Completion | Spring 2026 |
